![]() Sellas Life Sciences SELLAS Life Sciences is a clinical biopharmaceutical company focused on the development of cancer immunotherapies. | ![]() Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. | ![]() Tosk Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment. | ![]() Bionomics Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders. | |
Founding Date | Founding Date 2006 | Founding Date 2018 | Founding Date 2008 | Founding Date 1996 |
Type | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations New York, US HQ New York, US | Locations Houston, US HQ | Locations Mountain View, US HQ Sunnyvale, US | Locations Eastwood, AU HQ |
Employees | Employees 538% decrease | Employees 888% decrease | Employees 109% decrease | Employees 7 |
Valuation ($) | Valuation ($) 79.1 m | Valuation ($) 36.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $264k (FY, 2022) |
Net income | Net income ($26.9m) (FY, 2025) | Net income ($12.2m) (FY, 2025) | Net income N/A | Net income ($21.8m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 8.6m | Total funding raised $ 10.4m |

Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View company
Tosk is a biopharmaceutical company that provides drug development solutions for cancer treatment.
View company
Bionomics is a clinical-stage biopharmaceutical company developing ion channels targeting drug candidates designed for patients suffering from central nervous system (CNS) disorders.
View company